Avanir docosanol 10% cream
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Topical treatment for oral-facial herpes is "approvable" May 31. Approval is expected in the third quarter after minor labeling issues are addressed with FDA, the company says. Avanir predicts that docosanol will be the first FDA-approved OTC cold sore product. SmithKline Beecham Consumer Healthcare will market the produc